Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Dosimetric comparison of deep-inspiration breath-hold and free-breathing treatment delivery techniques for left-sided breast cancer using 3D surface tracking.

Vuong W, Garg R, Bourgeois DJ, Yu S, Sehgal V, Daroui P.

Med Dosim. 2019 Autumn;44(3):193-198. doi: 10.1016/j.meddos.2018.06.002. Epub 2018 Aug 3.

PMID:
30078605
2.

Recurrent squamous cell carcinoma involving cranial nerves in a patient with left glottic carcinoma treated with definitive radiation therapy: A case report.

Sindhu K, Armstrong W, Hasso A, Farzaneh T, Daroui P.

Pract Radiat Oncol. 2017 Mar - Apr;7(2):100-102. doi: 10.1016/j.prro.2016.11.004. Epub 2016 Nov 13. No abstract available.

3.

Response to Letter to the Editor: Regarding "The dosimetric impact of image guided radiation therapy by intratumoral fiducial markers".

Yu S, Sehgal V, Al-Ghazi M, Lawrenson L, Wei R, Kuo J, Daroui P, Ramsinghani N.

Pract Radiat Oncol. 2017 Jan - Feb;7(1):e87. doi: 10.1016/j.prro.2016.08.015. Epub 2016 Sep 2. No abstract available.

PMID:
27889537
4.

Radiation dermatitis caused by a bolus effect from an abdominal compression device.

Connor M, Wei RL, Yu S, Sehgal V, Klempner SJ, Daroui P.

Med Dosim. 2016 Autumn;41(3):221-4. doi: 10.1016/j.meddos.2016.02.003. Epub 2016 Jun 2.

PMID:
27264694
5.

The dosimetric impact of image guided radiation therapy by intratumoral fiducial markers.

Yu S, Lawrenson L, Wei R, Sehgal V, Hanna N, Kuo J, Daroui P, Ramsinghani N, Al-Ghazi M.

Pract Radiat Oncol. 2016 Jul-Aug;6(4):276-83. doi: 10.1016/j.prro.2015.11.007. Epub 2015 Nov 14.

6.

ACR Appropriateness Criteria® Resectable Stomach Cancer.

Daroui P, Jabbour SK, Herman JM, Abdel-Wahab M, Azad N, Blackstock AW, Das P, Goodman KA, Hong TS, Jones WE 3rd, Kaur H, Konski AA, Koong AC, Kumar R, Pawlik TM, Small W Jr, Thomas CR Jr, Suh WW.

Oncology (Williston Park). 2015 Aug;29(8):595-602, C3. Review.

7.

Practice patterns in the delivery of radiation therapy after mastectomy among the University of California Athena Breast Health Network.

Mayadev J, Einck J, Elson S, Rugo H, Hwang S, Bold R, Daroui P, McCloskey S, Yashar C, Kim D, Fowble B.

Clin Breast Cancer. 2015 Feb;15(1):43-7. doi: 10.1016/j.clbc.2014.07.005. Epub 2014 Aug 15.

PMID:
25245425
8.

Three-year outcomes of a once daily fractionation scheme for accelerated partial breast irradiation (APBI) using 3-D conformal radiotherapy (3D-CRT).

Goyal S, Daroui P, Khan AJ, Kearney T, Kirstein L, Haffty BG.

Cancer Med. 2013 Dec;2(6):964-71. doi: 10.1002/cam4.157. Epub 2013 Oct 31.

9.

A novel paradigm in the treatment of oligometastatic non-small cell lung cancer.

Jabbour SK, Daroui P, Moore D, Licitra E, Gabel M, Aisner J.

J Thorac Dis. 2011 Mar;3(1):4-9. doi: 10.3978/j.issn.2072-1439.2010.12.09.

10.

Utilization of breast conserving therapy in stages 0, I, and II breast cancer patients in New Jersey: an American College of Surgeons National Cancer Data Base (NCDB) analysis.

Daroui P, Gabel M, Khan AJ, Haffty BG, Goyal S.

Am J Clin Oncol. 2012 Apr;35(2):130-5. doi: 10.1097/COC.0b013e318209aa57.

PMID:
21325935
11.

Hydrogen peroxide induces topoisomerase I-mediated DNA damage and cell death.

Daroui P, Desai SD, Li TK, Liu AA, Liu LF.

J Biol Chem. 2004 Apr 9;279(15):14587-94. Epub 2003 Dec 19.

12.

Characterization of ARC-111 as a novel topoisomerase I-targeting anticancer drug.

Li TK, Houghton PJ, Desai SD, Daroui P, Liu AA, Hars ES, Ruchelman AL, LaVoie EJ, Liu LF.

Cancer Res. 2003 Dec 1;63(23):8400-7.

Supplemental Content

Loading ...
Support Center